Executive readout · one minute
What the filings say
- 8-K earnings release · filed Nov 5, 2026
- Prestige Consumer Healthcare Inc. reported Q2 revenue of $336.3 million, up 22.7%, and adjusted diluted EPS of $1.13. Fiscal 2027 guidance fell to $1,280 to $1,290 million revenue and $4.48 to $4.55 adjusted diluted EPS due to Clear Eyes production variability at Pillar5.
- 10-Q report · filed Nov 5, 2026
- Prestige Consumer Healthcare reported revenue growth of 22.7% for the three months ended September 30, 2026, but gross margin fell to 51.3% from 55.3%. Interest expense rose to $30.0 million, while outstanding indebtedness reached $2.1 billion as September 30, 2026.
The audio replay and transcript follow the call.